Anti-CD20

1 Drug classified under this drug class

Anti-CD20, anti-CD3. Epcoritamab 5 mg/ml, 60 mg/ml.
Vial, Sol. for inj. 1 X 4 mg/0.8 ml or 48 mg
To be admin in cycles of 28 days as per full prescription info. Pre-medication needed.
For adults with relapsed or refractory diffuse large B-cell
lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high grade B cell lymphoma after two or more lines of syst. ther.
As monother. for adults with relapsed or refractory follicular
lymphoma (FL) after two or more lines of syst. ther/
C/I:  Hypersens.